RAPT Therapeutics(RAPT)
Focus: RAPT Therapeutics is a public biotechnology company focused on immune-targeted cancer therapies and inflammatory disease treatments. Founded in 2015 and headquartered in South San Francisco, the company operates as a mid-cap biotech with a diversified pipeline across oncology and immunology.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About RAPT Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow RAPT Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$2M
Pipeline & Clinical Trials
FLX925
Acute Myeloid LeukemiaClinical Trials (1)
NCT02335814First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Phase 1Help build intelligence for RAPT Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.